Genotyping Market by Manufacturers, Countries, Type and Application, Forecast to 2022
According to Stratistics
MRC, the Global Genotyping market is estimated at $8.64 billion in 2016 and is
expected to reach $31.19 billion by 2023 growing at a CAGR of 20.1% from 2016
to 2023. Growing awareness regarding personalized medicine and genetic diseases
among the people, increase in target diseases occurrence and technological
improvements in genotyping are the key factors driving the market growth. On
the other hand, poor reimbursement policies are hampering the market growth.
Demand for low cost genotyping service and huge flow of investments are the
opportunities for the market to grow.
Genotyping is the
procedure of deciding differences in the genetic make-up (genotype) of an
individual by analyzing the individual's DNA sequence utilizing biological
assays and comparing it to a reference sequence. It brings out the alleles an
individual has inherited from their parents. The reagents and kits lead the
market with the highest market share due to their wide usage and growing demand
for genotyping tests. Personalized medicine holds the largest share and the
growth can be attributed to increasing support of government for personalized
medicine. North America is projected to be the leading markets in terms of
market size, the growth is attributed to R&D investments and technological
advancements. Asia Pacific is expected to witness high growth rate during the
forecast period.
Some of the key players in the global genotyping market are GE Healthcare, Illumina, Inc, Agilent Technologies, Life Technologies Corporation (Thermofisher Scientific), Beckman Coulter, Roche, Qiagen NV, Affymetrix, Inc, Fluidigm Corp, Sequenom Inc, Douglas Scientific LLC, Premium Biosoft and Genewiz, Inc.
Technologies Covered:
• Sequencing
• Polymerase Chain Reaction (PCR)
• Capillary Electrophoresis
• Maldi-Tof
• Microarray
• Mass spectrometry
• Other Technologies
End-Users Covered:
• Diagnostic & Research Laboratories
• Pharmaceutical & Biopharmaceutical Companies
• Academic Institutions
Some of the key players in the global genotyping market are GE Healthcare, Illumina, Inc, Agilent Technologies, Life Technologies Corporation (Thermofisher Scientific), Beckman Coulter, Roche, Qiagen NV, Affymetrix, Inc, Fluidigm Corp, Sequenom Inc, Douglas Scientific LLC, Premium Biosoft and Genewiz, Inc.
Technologies Covered:
• Sequencing
• Polymerase Chain Reaction (PCR)
• Capillary Electrophoresis
• Maldi-Tof
• Microarray
• Mass spectrometry
• Other Technologies
End-Users Covered:
• Diagnostic & Research Laboratories
• Pharmaceutical & Biopharmaceutical Companies
• Academic Institutions
Full report with Table of
Content: https://marketreportscenter.com/reports/571532/genotyping-global-market-outlook-2017-2023
Applications Covered:
• Pharmacogenomics
• Diagnostic Research
• Agricultural Biotechnology
• Animal Genetics
• Personalized medicine
• Drug discovery and development
• Other Applications
Product and Services Covered:
• Reagents & Kits
• Instruments
• Bioinformatics Software
• Genotyping Services
• Pharmacogenomics
• Diagnostic Research
• Agricultural Biotechnology
• Animal Genetics
• Personalized medicine
• Drug discovery and development
• Other Applications
Product and Services Covered:
• Reagents & Kits
• Instruments
• Bioinformatics Software
• Genotyping Services
…
About
Market Reports Center;
Market Reports Center is an e-commerce platform
obliging the needs of knowledge workers, experts, professionals who are subject
to market research information for their work, or to make strategic business
decisions. We are dedicated to create a comprehensive offering of market
research which is accurate, credible and affordable.
Connect
for more details:
Sam
Collins
Market
Reports Center
1-646-883-3044
(US)
Comments
Post a Comment